Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4225473

O=C(CNCc1ccc(Cl)cc1Cl)N(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
TP53 P04637 1/20 0.45
POLQ O75417 1/20 0.45
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 4/20 0.43
TSHR P16473 2/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNA1B Q00975 1/20 0.41
CACNB1 Q02641 1/20 0.41
CACNA1C Q13936 1/20 0.41
EPHX2 P34913 1/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
PPARG P37231 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4226561 0.79 RAB9A (0.49) LMNATP53L3MBTL1ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL4233867 0.79 POLQ (0.50) POLQALDH1A1EPHX2PPARGHTT
Trifluoroacetic Acid SCHEMBL4227420 0.79 ALDH1A1 (0.43) LMNAPOLQATMALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL4233596 0.79 KMT2A (0.40) LMNAPOLQALDH1A1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL5098273 0.78 TACR1 (0.45) LMNAPOLQALDH1A1KMT2ANPC1
Trifluoroacetic Acid SCHEMBL4235482 0.77 P2RX7 (0.41) ALDH1A1KMT2AMEN1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL4223287 0.76 HDAC3 (0.43) ALDH1A1KMT2AMEN1EPHX2PPARG
Trifluoroacetic Acid SCHEMBL4235529 0.75 KDM4E (0.50) LMNAATML3MBTL1ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL4227826 0.71 CACNA2D1 (0.48) POLQALDH1A1KMT2AMEN1CACNA2D1
Hydrochloric Acid SCHEMBL4233574 0.71 POLB (0.51) LMNATP53L3MBTL1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096104-A1 Organic diamines as mGluR7 modulators Novartis AG (CH) 2009-09-02 EP disclosed
US-20080242698-A1 Organic Compounds NOVARTIS AG (CH) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242698-A1 Organic Compounds AOC1, OTC, ODC1 LMNA 3423/4885TP53 3167/4885POLQ 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.